Frank Wischnewski, Ph.D.

Dr. Wischnewski has over ten years of post-graduate experience in scientific research and development at the University Medical Center Hamburg-Eppendorf and the department of Biochemistry at the University of Potsdam using cell-based, and pre-clinical models to address vaccination in cancer diseases. Since coming to IPM Biotech, his areas of expertise include the development and validation of immunogenicity (screening/confirmatory/ neutralizing) and PK assays using ELISA, RIA and ECL-based immunoassays (MSD) under GLP regulations.

Frank has co-authored peer-reviewed publications and has presented at international scientific meetings. He has received an award from the Department of Tumor Biology at University Medical Center Hamburg-Eppendorf. Frank has a Diploma degree in Biochemistry/Molecular Biology from the University of Hamburg (Germany) and graduated in Tumor Biology.